APP and Alzheimer disease: Administration of an ubiquitin C-terminal hydrolase L1 (Uch-L1)—an enzyme associated with the breakdown of excess or abnormal proteins, has a protective effect on memory loss in a mouse model of AD (APP Sw-PS1M146V) [51].